In 1993 was created Montreux Equity Partners, which is appeared as VC. The main department of described VC is located in the San Francisco. The fund was located in North America if to be more exact in United States.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Montreux Equity Partners, startups are often financed by OrbiMed, Frazier Healthcare Partners, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Frazier Healthcare Partners, Skyline Ventures, Sequoia Capital. In the next rounds fund is usually obtained by Domain Associates, OrbiMed, Skyline Ventures.
The fund was created by Daniel Turner. We also calculated 5 valuable employees in our database.
Among the most popular fund investment industries, there are Internet, Computer. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight MINDBODY, Tobira Therapeutics, GC Aesthetics. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.
The high activity for fund was in 2007. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. This Montreux Equity Partners works on 1 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The average startup value when the investment from Montreux Equity Partners is 10-50 millions dollars. The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2007.
Funds with similar focus
|Channel 4 Ventures||England, London, United Kingdom|
|Credit Suisse Entrepreneur Capital||-|
|Cybozu Japan||Japan, Tokyo|
|East Gate Capital Management||California, Los Altos, United States|
|FRACTALS||Novi Sad, Serbia, Vojvodina|
|France Angels||France, Ile-de-France, Paris|
|Good Energies||New York, New York, United States|
|HiCTO Venture||China, Shanghai|
|internet24||Dresden, Germany, Sachsen|
|Kuanhua Investment Group||China, Hangzhou, Zhejiang|
|Lincoln Road Global Management||Florida, Miami, United States|
|Shanghai Lin Chong Investment Management||-|
|Shijiazhuang Deheng Investment Center||China, Hebei, Shijiazhuang|
|Silicon Valley Data Capital||California, Mountain View, United States|
|Upward||New York, New York, United States|
|Xinqi Investment||China, Shanghai|
|Yuanzhi Technology Group||-|
|$72M||06 Jul 2022||Corona Del Mar, California, United States|
|$20M||14 Jun 2022||Miami, Florida, United States|
|$15M||28 Mar 2022||Upper Merion Township, Pennsylvania, United States|
|$5M||12 Nov 2020||Upper Merion Township, Pennsylvania, United States|
|$11M||08 Oct 2020||Santa Monica, California, United States|
|$65M||09 May 2019||Redwood City, California, United States|
|03 May 2019||Johnson City, Tennessee, United States|
|$97M||30 Oct 2018||Dublin|
|$4M||06 Mar 2018||California, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.